In addition, either eIF4A2 knockdown or inhibition by silvestrol significantly suppresses colorectal cancer invasion and migration as well as enhances sensitivity to oxaliplatin treatment both in vitro and in vivo (Chen et al., 2019). This evidence concerns the gene EIF4A2 and colorectal cancer.